3.5.1.12: biotinidase
This is an abbreviated version!
For detailed information about biotinidase, go to the full flat file.
Word Map on EC 3.5.1.12
-
3.5.1.12
-
newborn
-
children
-
seizure
-
infant
-
urine
-
holocarboxylase
-
inborn
-
child
-
hearing
-
acidosis
-
alopecia
-
phenylketonuria
-
carboxylases
-
biotinylation
-
symptomatic
-
treatable
-
biotin-dependent
-
ataxia
-
hypotonia
-
hypothyroidism
-
late-onset
-
rash
-
galactosemia
-
acidurias
-
avidin
-
homocystinuria
-
maple
-
acidemia
-
medicine
-
syrup
-
lipoylated
-
biotin-responsive
-
neurocutaneous
-
lethargy
-
biotin-binding
-
paraparesis
-
biotin-deficient
-
seborrheic
-
hyperammonemia
-
3-methylcrotonyl-coa
-
diagnostics
-
analysis
- 3.5.1.12
- newborn
- children
- seizure
- infant
- urine
- holocarboxylase
-
inborn
- child
-
hearing
- acidosis
- alopecia
- phenylketonuria
- carboxylases
-
biotinylation
-
symptomatic
-
treatable
-
biotin-dependent
- ataxia
- hypotonia
- hypothyroidism
-
late-onset
- rash
- galactosemia
- acidurias
- avidin
- homocystinuria
-
maple
- acidemia
- medicine
- syrup
-
lipoylated
-
biotin-responsive
-
neurocutaneous
- lethargy
-
biotin-binding
- paraparesis
-
biotin-deficient
-
seborrheic
-
hyperammonemia
- 3-methylcrotonyl-coa
- diagnostics
- analysis
Reaction
Synonyms
amidohydrolase biotinidase, biocytin hydrolyzing amidase, biotinidase, biotinyl-hydrolase, BTD, lipoamidase, lipolysine hydrolase, lipoyl-X-hydrolase
ECTree
Advanced search results
Application
Application on EC 3.5.1.12 - biotinidase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
analysis
-
identification of the site of carboxylation of the biotinyl prosthetic group of several biotin enzymes
diagnostics
medicine
BTD is a biomarker for the hepatic glycogen storage disease, overview
diagnostics
BTD is a potential serological biomarker for the detection of breast cancer to use with plasma
diagnostics
loss of overall biotinidase expression is a marker for papillary thyroid cancer aggressiveness acting as a predictor of disease progression and prognosis
-
plasma biotinidase activity assay for diagnosis and screen newborn infants for biotinidase deficiency, treatment of inborn metabolism errors with large doses of biotin
medicine
-
naturally occuring missense mutations result in biotinidase deficiency, an autosomal recessively inherited disorder in which affected individuals have multiple carboxylase deficiency due to secondary deficiency of free biotin
medicine
-
thirteen novel mutations in children with biotinidase deficiency. Biotinidase deficiency is a defect in the recycling of the vitamin biotin. Biotin supplementation can markedly improve the neurological and cutaneous symptoms of affected children and prevents symptoms in children identified by newborn screening or treated since birth
medicine
-
serum biotinidase is a sensitive and specific biochemical marker of hepatic dysfunction